Suven Pharmaceuticals consolidated net profit rises 10.29% in the March 2022 quarter

Sales rise 40.40% to Rs 363.85 crore

Net profit of Suven Pharmaceuticals rose 10.29% to Rs 91.67 crore in the quarter ended March 2022 as against Rs 83.12 crore during the previous quarter ended March 2021. Sales rose 40.40% to Rs 363.85 crore in the quarter ended March 2022 as against Rs 259.16 crore during the previous quarter ended March 2021.

For the full year,net profit rose 25.24% to Rs 453.80 crore in the year ended March 2022 as against Rs 362.34 crore during the previous year ended March 2021. Sales rose 30.75% to Rs 1320.22 crore in the year ended March 2022 as against Rs 1009.72 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales363.85259.16 40 1320.221009.72 31 OPM %43.1636.15 -43.8943.62 - PBDT171.70113.78 51 706.69499.31 42 PBT161.28105.47 53 667.59467.67 43 NP91.6783.12 10 453.80362.34 25

Powered by Capital Market - Live News